0 CHECKOUT

PRODUCT FILTERS

REGION

8
1

CATEGORIES

  • 47
  • 35
  • 34
  • 21
  • 6
  • 6
  • 4
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

24
29
99
122

PUBLISHED

0
8
28
122

PRODUCT TYPE

86
33
2
1

Search for: "Neuropathy Therapy Area Pipeline Report"

Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2016

Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2016 Summary The report ‘Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2016’, provides an overview of the Peripheral...

Published:  February 2016
Price:  From

Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2015

Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2015 Summary The report ‘Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2015’, provides an overview of the Peripheral...

Published:  July 2015
Price:  From

Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2015

Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2015 Summary This, ‘Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2015’, provides an overview of the Peripheral...

Published:  January 2015
Price:  From

Diabetic Neuropathy - Pipeline Review, H1 2015

Diabetic Neuropathy - Pipeline Review, H1 2015 Summary This, ‘Diabetic Neuropathy - Pipeline Review, H1 2015’, provides an overview of the Diabetic Neuropathy’s therapeutic pipeline. This report...

Published:  June 2015
Price:  From

Diabetic Neuropathy - Pipeline Review, H2 2015

Diabetic Neuropathy - Pipeline Review, H2 2015 Summary The report ‘Diabetic Neuropathy - Pipeline Review, H2 2015’, provides an overview of the Diabetic Neuropathy’s therapeutic pipeline. This report...

Published:  December 2015
Price:  From

Optic Neuropathy - Pipeline Review, H2 2015

Optic Neuropathy - Pipeline Review, H2 2015 Summary The report ‘Optic Neuropathy - Pipeline Review, H2 2015’, provides an overview of the Optic Neuropathy’s therapeutic pipeline. This report provides...

Published:  August 2015
Price:  From

Diabetic Peripheral Neuropathy - Pipeline Review, H2 2015

Diabetic Peripheral Neuropathy - Pipeline Review, H2 2015 Summary The report ‘Diabetic Peripheral Neuropathy - Pipeline Review, H2 2015’, provides an overview of the Diabetic Peripheral Neuropathy’s...

Published:  July 2015
Price:  From

Diabetic Peripheral Neuropathy - Pipeline Review, H1 2015

Diabetic Peripheral Neuropathy - Pipeline Review, H1 2015 Summary This, ‘Diabetic Peripheral Neuropathy - Pipeline Review, H1 2015’, provides an overview of the Diabetic Peripheral Neuropathy’s therapeutic...

Published:  January 2015
Price:  From

Diabetic Peripheral Neuropathy - Pipeline Review, H1 2016

Diabetic Peripheral Neuropathy - Pipeline Review, H1 2016 Summary The report ‘Diabetic Peripheral Neuropathy - Pipeline Review, H1 2016’, provides an overview of the Diabetic Peripheral Neuropathy...

Published:  February 2016
Price:  From

Optic Neuropathy - Pipeline Review, H1 2016

Optic Neuropathy - Pipeline Review, H1 2016 Summary ‘Optic Neuropathy - Pipeline Review, H1 2016’, provides an overview of the Optic Neuropathy pipeline landscape. The report provides comprehensive...

Published:  March 2016
Price:  From

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2016

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2016 Summary ‘Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2016’, provides an overview of the Chemotherapy Induced...

Published:  March 2016
Price:  From

Optic Neuropathy - Pipeline Review, H1 2015

Optic Neuropathy - Pipeline Review, H1 2015 Summary This, ‘Optic Neuropathy - Pipeline Review, H1 2015’, provides an overview of the Optic Neuropathy’s therapeutic pipeline. This report provides...

Published:  January 2015
Price:  From

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2015

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2015 Summary This ‘Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2015’, provides an overview of the Chemotherapy...

Published:  February 2015
Price:  From

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2015

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2015 Summary The report ‘Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H2 2015’, provides an overview of the Chemotherapy...

Published:  September 2015
Price:  From

Gene Therapy - Technologies, Markets and Companies

Gene therapy can be broadly defined as the transfer of defined genetic material to specific target cells of a patient for the ultimate purpose of preventing or altering a particular disease state. Genes...

Published:  June 2016
Price:  From

Leber's Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Pipeline Review, H2 2015

Leber’s Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Pipeline Review, H2 2015 Summary The report ‘Leber’s Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Pipeline Review,...

Published:  September 2015
Price:  From

Leber's Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Pipeline Review, H1 2016

Leber’s Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Pipeline Review, H1 2016 Summary ‘Leber’s Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Pipeline Review, H1 2016’, provides...

Published:  March 2016
Price:  From

Leber's Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Pipeline Review, H1 2015

Leber’s Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Pipeline Review, H1 2015 Summary This, ‘Leber’s Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Pipeline Review, H1 2015’,...

Published:  February 2015
Price:  From

Immunoglobulins Market to 2017 - Off-Label Usage and Treatment of Primary Immunodeficiency Diseases and Neurological Disorders Stimulate Market Growth

“Immunoglobulins Market to 2017 - Off-Label Usage and Treatment of Primary Immunodeficiency Diseases and Neurological Disorders Stimulate Market Growth” provides in-depth analysis of the, drivers and...

Published:  September 2011
Price:  From

Peripheral Neuropathy and Neuropathic Pain 2008

This report estimates that Peripheral Neuropathy (PN) and Neuropathic Pain (NP) affect 170 to 270 million individuals globally PN and NP are causally linked to a number of diseases, however diabetes,...

Published:  June 2009
Price:  From
Loading Indicator

Our Clients

  • Procter & Gamble Co.
  • Western Union Company
  • Volvo Car Corporation
  • Morgan Stanley
  • SAP SE
  • LG Corporation
  • Roche Diagnostics Ltd.